Background: Deregulation of orexigenic and anorexigenic pathways occurs among adolescents with obesity. Alpha-melanocyte-stimulating hormone (α-MSH) is a key catabolic mediator of energy homeostasis and an important anorexigenic neuropeptide in the control of energy balance and thermogenesis. However, it was not well explored if α-MSH can modulate long-term weight loss therapy responses in a dependent manner according to its concentration. Our hypothesis is that a high α-MSH concentration at baseline promotes better modulation of anorexigenic/orexigenic pathways in obese adolescents. Methods: One hundred ten post-pubertal obese adolescents (body mass index >95th percentile) were submitted to 1 year of interdisciplinary therapy (clinical, nutritional, psychological, physical exercise, and physiotherapy support). Body composition and plasma levels of α-MSH, neuropeptide Y (NPY), melanin-concentrating hormone, and agouti-related peptide (AgRP) were measured before and after therapy. The volunteers were grouped on the basis of Tertiles of α-MSH concentration: Low (<0.75 ng/mL), Medium (≤0.76 to ≥1.57 ng/mL), and High (>1.57 ng/mL). Significance was set as p < 0.05. Results: The treatment promoted a significant improvement in body adiposity and fat free mass for all groups. It is important to note that only in the high α-MSH group, a significant increase of the α-MSH/NPY ratio and decrease NPY/AgRP ratio post treatment were observed. Conclusion: The high α-MSH concentration promotes better modulation of anorexigenic/orexigenic pathways in obese adolescents following long-term weight loss therapy and this is important in clinical practice.

Keywords:
Energy balance, Obesity, Adolescents
1.
Roh E, Kim MS: Brain regulation of energy metabolism. Endocrinol Metab (Seoul) 2016; 31: 519–524.
2.
Fuqua JS, Rogol AD: Neuroendocrine alterations in the exercising human: implications for energy homeostasis. Metabolism 2013; 62: 911–921.
3.
Dhillo WS: Appetite regulation: an overview. Thyroid 2007; 17: 433–445.
4.
Shipp SL, Cline MA, Gilbert ER: Recent advances in the understanding of how neuropeptide Y and α-melanocyte stimulating hormone function in adipose physiology. Adipocyte 2016; 5: 333–350.
5.
Oyama LM, do Nascimento CM, Carnier J, de Piano A, Tock L, Sanches Pde L, Gomes FA, Tufik S, de Mello MT, Dâmaso AR: The role of anorexigenic and orexigenic neuropeptides and peripheral signals on quartiles of weight loss in obese adolescents. Neuropeptides 2010; 44: 467–474.
6.
Hoggard N, Johnstone AM, Faber P, Gibney ER, Elia M, Lobley G, Rayner V, Horgan G, Hunter L, Bashir S, Stubbs RJ: Plasma concentrations of alpha-MSH, AgRP and leptin in lean and obese men and their relationship to differing states of energy balance perturbation. Clin Endocrinol (Oxf) 2004; 61: 31–39.
7.
Dâmaso AR, de Piano A, Sanches PL, Corgosinho F, Tock L, Oyama LM, Tock L, do Nascimento CM, Tufik S, de Mello MT: Hyperleptinemia in obese adolescents deregulates neuropeptides during weight loss. Peptides 2011; 32: 1384–1391.
8.
Vehapoğlu A, Türkmen S, Terzioğlu Ş: Alpha-melanocyte-stimulating hormone and agouti-related protein: do they play a role in appetite regulation in childhood obesity? J Clin Res Pediatr Endocrinol 2016; 8: 40–47.
9.
Dâmaso AR, de Piano A, Campos RM, Corgosinho FC, Siegfried W, Caranti DA, Masquio DC, Carnier J, Sanches Pde L, Leão da Silva P, Nascimento CM, Oyama LM, Dantas AD, de Mello MT, Tufik S, Tock L: Multidisciplinary approach to the treatment of obese adolescents: effects on cardiovascular risk factors, inflammatory profile, and neuroendocrine regulation of energy balance. Int J Endocrinol 2013; 2013: 541032.
10.
Feichtinger RG, Pétervári E, Zopf M, Vidali S, Aminzadeh-Gohari S, Mayr JA, Kofler B, Balaskó M: Effects of alpha-melanocyte-stimulating hormone on mitochondrial energy metabolism in rats of different age-groups. Neuropeptides 2017; 64: 123–130.
11.
Carnier J, de Mello MT, Ackel-DElia C, Corgosinho FC, Campos RM, Sanches Pde L, Masquio DC, Bueno CR Jr, Ganen Ade P, Martins AC, Caranti DA, Tock L, Clemente AP, Tufik S, Dâmaso AR: Aerobic training (AT) is more effective than aerobic plus resistance training (AT+RT) to improve anorexigenic/orexigenic factors in obese adolescents. Appetite 2013; 69: 168–173.
12.
Cook CM, Schoeller DA: Physical activity and weight control: conflicting findings. Curr Opin Clin Nutr Metab Care 2011; 14: 419–424.
13.
Tanner JM, Whitehouse RH: Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976; 51: 170–179.
14.
NCR. Dietary Reference Intake: Applications in Dietary Assessment. Washington, National Academic Press, 2001.
15.
Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK; American College of Sports Medicine: American college of sports medicine position stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 2009; 41: 459–471.
16.
Rostás I, Füredi N, Tenk J, Mikó A, Solymár M, Soós S, Székely M, Pétervári E, Balaskó M: Age-related alterations in the central thermoregulatory responsiveness to alpha-MSH. J Therm Biol 2015; 49–50: 9–15.
17.
Mountjoy KG: Distribution and function of melanocortin receptors within the brain. Adv Exp Med Biol 2010; 681: 29–48.
18.
Rodrigues AR, Almeida H, Gouveia AM: Alpha-MSH signalling via melanocortin 5 receptor promotes lipolysis and impairs re-esterification in adipocytes. Biochim Biophys Acta 2013; 1831: 1267–1275.
19.
Richard D, Monge-Roffarello B, Chechi K, Labbé SM, Turcotte EE: Control and physiological determinants of sympathetically mediated brown adipose tissue thermogenesis. Front Endocrinol (Lausanne) 2012; 3: 36.
20.
Song CK, Vaughan CH, Keen-Rhinehart E, Harris RB, Richard D, Bartness TJ: Melanocortin-4 receptor mRNA expressed in sympathetic outflow neurons to brown adipose tissue: neuroanatomical and functional evidence. Am J Physiol Regul Integr Comp Physiol 2008; 295:R417–R428.
21.
Soos S, Petervari E, Szekely M, Jech-Mihalffy A, Balasko M: Complex catabolic effects of central alpha-MSH infusion in rats of altered nutritional states: differences from leptin. J Mol Neurosci 2011; 43: 209–216.
22.
Nuzzaci D, Laderrière A, Lemoine A, Nédélec E, Pénicaud L, Rigault C, Benani A: Plasticity of the melanocortin system: determinants and possible consequences on food intake. Front Endocrinol (Lausanne) 2015; 14: 143.
23.
Ackel-D’Elia C, Campos RMS, Corgosinho FC, Masquio DCL, Clemente APG, Tock L, de Mello MT, Tufik S, Dâmaso AR: Aerobic plus resistance training on pro-anti-inflammatory adipokinesin obese adolescents. Eur J Sport Exe Sci 2014; 3: 5–17.
24.
Campos RM, de Mello MT, Tock L, Silva PL, Masquio DC, de Piano A, Sanches PL, Carnier J, Corgosinho FC, Foschini D, Tufik S, Dâmaso AR: Aerobic plus resistance training improves bone metabolism and inflammation in adolescents who are obese. J Strength Cond Res 2014; 28: 758–766.
25.
Sanches PL, de Mello MT, Elias N, Fonseca FA, Campos RM, Carnier J, de Piano A, Masquio DC, Silva PL, Oyama LM, Corgosinho FC, Nascimento CM, Tock L, D’Elia CA, Tufik S, Dâmaso AR: Hyperleptinemia: implications on the inflammatory state and vascular protection in obese adolescents submitted to an interdisciplinary therapy. Inflammation 2014; 37: 35–43.
26.
Dâmaso AR, da Silveira Campos RM, Caranti DA, de Piano A, Fisberg M, Foschini D, de Lima Sanches P, Tock L, Lederman HM, Tufik S, de Mello MT: Aerobic plus resistance training was more effective in improving the visceral adiposity, metabolic profile and inflammatory markers than aerobic training in obese adolescents. J Sports Sci 2014; 32: 1435–1445.
27.
de Piano A, de Mello MT, Sanches Pde L, da Silva PL, Campos RM, Carnier J, Corgosinho F, Foschini D, Masquio DL, Tock L, Oyama LM, do Nascimento CM, Tufik S, Dâmaso AR: Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents. Eur J Gastroenterol Hepatol 2012; 24: 1313–1324.
28.
Masquio DC, de Piano A, Campos RM, Sanches PL, Carnier J, Corgosinho FC, Netto BD, Carvalho-Ferreira JP, Oyama LM, Nascimento CM, de Mello MT, Tufik S, Dâmaso AR: The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents. Br J Nutr 2015; 113: 1920–1930.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.